Ingevity Corp
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Inventories, net
Index
Note 6: Inventories, net
| December 31, | ||
|---|---|---|
| In millions | 2023 | 2022 |
| Raw materials | $128.3 | $106.7 |
| Production materials, stores and supplies | 26.0 | 27.9 |
| Finished and in-process goods | 255.2 | 228.2 |
| Subtotal | $409.5 | $362.8 |
| Less: LIFO reserve (1) | (100.7) | (27.8) |
| Inventories, net | $308.8 | $335.0 |
(1) The increase in the LIFO balance in 2023 is primarily attributable to the significant inflation in the price of crude tall oil ("CTO") which is the primary raw material for our Performance Chemicals reportable segment.
As of December 31, 2023, approximately 27 percent,8 percent, and 65 percent of our Inventories, net, were accounted for under the FIFO, average cost, and LIFO methods, respectively. As of December 31, 2022, approximately 47 percent,8 percent, and 45 percent of our Inventories, net, were accounted for under the FIFO, average cost, and LIFO methods, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.